Amplitude-integrated EEG assists in detecting cerebral dysfunction in the newborn

Background: Amplitude-integrated encephalography (aEEG) in term-born encephalopathic infants has been shown to be predictive of later neurodevelopmental outcomes, but little is known about the mediating cerebral pathology. In addition, the aEEG is commonly used to monitor electrographic seizures in the newborn, an important manifestation of cerebral pathology, but there is limited data on it’s efficacy for this purpose. It’s clinical application in the preterm infant remains to be explored. Aim: The central aim of this thesis is to prove the hypothesis that the aEEG assists in detecting cerebral dysfunction in the newborn. Methods: 1) In a cohort of term-born infants with encephalopathy and/or seizures digital aEEG background measures of the lower and upper aEEG margins were related to a numeric MRI abnormality score. 2) In at-risk term newborns, the accuracy of two-channel digital aEEG monitoring was compared with continuous concurrent conventional EEG for seizure detection. 3) In preterm infants (gestation at birth < 30 weeks) aEEG measures of lower and upper margin collected in the first week of life were compared in infants with substantial cerebral abnormality to infants without. Results: 1) For all infants in the term cohort, the severity of abnormality of aEEG background was strongly related to severity of abnormality seen on cerebral MRI. 2) Using the aEEG pattern with the raw EEG signal, 76% of electrographic seizures were correctly identified in the term infants. 3) In the preterm cohort, the lower and upper aEEG amplitude margins increased significantly during the first week of life. In the presence of substantial cerebral abnormality, these margins were significantly depressed. Seizures were noted in the smaller and sicker, infants. Conclusion: The central hypothesis of this thesis, that the aEEG assists in detecting cerebral dysfunction in the newborn was proved

Study of the Term Neonatal Brain Injury with combined Diffuse Optical Tomography and Electroencephalography

This thesis describes the application of combined diffuse optical tomography (DOT) and electroencephalography (EEG) in the investigation of neonatal term brain injury. With hypoxic ischaemic encephalopathy (HIE) and perinatal stroke being the most frequent contributors to brain injury in the term neonatal population, the first part of the thesis focuses on the description and ongoing requirement for their further investigation. In continuation to that, the characteristics and unique properties of both DOT and EEG are described and explored. The combination of these two modalities was utilised in elucidating the relationship between neuronal activity and cerebral haemodynamics both in physiological processes as well as in disease, by the infant’s cot side. This work differs to previous studies using near-infrared technologies and EEG, as a denser whole head array was used, offering the potential of 3-dimensional image reconstruction of the cortical haemodynamic events in relation to electro-cortical activity. These methods were applied in the study of critically ill infants presenting with seizures in the first few days of life. The relevant results are presented in three separate chapters of the thesis. Distinct neurophysiological phenomena such as seizures and burst suppression were detected and studied in association to underlying HIE. On the grounds of a pre-existing pilot study of our research group, distinct prolonged de-oxygenated cortical areas were identified following electrical seizure activity. Further exploration of infants with seizures provided limited supporting evidence. The investigation of burst suppression in HIE led to the first ever identification of repeated, waveform, cortical haemodynamic events in response to bursts of electrical activity with some spatial correlation to regions of brain injury. Further analysis of the low frequencies within the diffuse optical signal in cases of perinatal stroke, showed a consistent interhemispheric difference between the healthy and stroke-affected brain regions. The limitations, prospects and conclusions are presented in the final chapter. The use of simultaneous DOT and EEG offers a unique neuro-monitoring and neuro-investigating tool in the neonatal intensive care environment, which is safe, portable, and cost-effective, Ongoing research is required for the exploration and development of the methodology and its potential diagnostic properties

Tehohoitopotilaiden neuromonitorointi

In critical illness the risk of neurological insults is high, whether because of the illness itself, or as a treatment complication. As a result, the length of hospital stay and the risk of both further morbidity and mortality are all roughly doubled. One of the major challenges is the inability to monitor a sedated, mechanically ventilated patient’s neurological symptoms during intensive care treatment, due to a lack of reliable methods. The aims of this thesis research were to identify and test potential non-invasive methods, which would be predictive of neurological outcome, showing potential as neuromonitoring methods of critical care patients unable to self-report. As a guiding theme, all tested methods could be applied to actual critical care with relative ease. Patients were included from two groups with a notably high incidence of neurological complications, namely acute liver failure patients with hepatic encephalopathy (I), and aortic surgery patients operated during hypothermic circulatory arrest (II). The first group included 20 patients, and the latter 30 patients. Late mortality and quality of life was assessed for the aortic surgery patients (III), and the postoperative development of certain blood biomarkers (IV). The tested non-invasive neuromonitoring methods included electroencephalogram (EEG) variables from frontal or fronto-temporal abbreviated monitoring, frontal near-infrared spectroscopy, transcranial Doppler ultrasound measurements of the intracranial blood flow, and finally biomarkers. The last included established biomarkers with an association with neurological complications, namely neuron-specific enolase, and protein S100β, and several interesting biomarkers normally associated with tumours and pancreatitis. Of the tested methods, the frontal EEG variables showed greatest promise, but the addition of the temporal channels did not increase sensitivity. Spectral EEG variables were predictive of the stage of hepatic encephalopathy (I), while a novel EEG variable called wavelet subband entropy was predictive of neurological outcome (I). The hemispheric asymmetry of frontal EEG was reasonably predictive of neurological outcome after aortic surgery (II). None of the other tested methods were predictive of outcome (I, II, IV), except protein S100β, which was significantly higher in the poor outcome group 48 to 72 hours after hypothermic circulatory arrest (II). The quality of life of aortic surgery patients was good after 5 to 8 years, and comparable with the general population of chronically ill patients (III). The aim of this explorative research was to identify and test non-invasive neuromonitoring methods, suitable for use in critical care. Based on the results, frontal EEG variables are promising and predict the grade of hepatic encephalopathy and neurological outcome. The other tested methods were not predictive of neurological outcome. The long-term quality of life of aortic surgery patients is very good, despite the high risk for neurological complications.Kriittisissä sairauksissa neurologisen komplikaation riski on suuri, sekä itse kriittisen sairauden että varsinaisen hoidon seurauksena. Haittatapahtuman johdosta sairaalahoidon kesto sekä sairastuvuuden ja kuolleisuuden riskit kaksinkertaistuvat. Yksi suurimmista haasteista on luotettavien menetelmien puute, joilla voitaisiin arvioida mekaanisen hengitystuen varassa olevan ja rauhoittavia lääkkeitä saavan potilaan neurologisia oireita tehohoidon aikana. Tämän väitöskirjatyön tarkoituksena oli tunnistaa ja testata lupaavia ei-kajoavia menetelmiä, jotka ennustaisivat neurologista lopputulosta, ja jotka soveltuisivat kriittisesti sairaan tehohoitopotilaan neuromonitorointiin. Kantavana teemana kaikki testatut menetelmät voitaisiin soveltaa kliiniseen työhön suhteellisen helposti. Potilaita kerättiin kahteen ryhmään, joissa neurologisten komplikaatioiden esiintyvyys on huomattavan suuri. Ensimmäinen ryhmä käsitti akuuttia maksan vajaatoimintaa ja hepaattista enkefalopatiaa sairastavat potilaat (I), toinen hypotermisen verenkierron pysäytyksen aikana rinta-aortan leikkauksen läpikäyvät potilaat (II). Ensimmäiseen ryhmään kuului 20 potilasta, jälkimmäiseen 30 potilasta. Aorttaleikatuilta potilailta arvioitiin myös elämänlaatua sekä myöhäiskuolleisuutta (III), lisäksi tiettyjen biomerkkiaineiden aorttaleikkauksen jälkeistä kehitystä ja soveltuvuutta neuromonitorointiin arvioitiin yhdessä osatyössä (IV). Tutkimuksessa arvioituihin ei-kajoaviin neuromonitorointimenetelmiin lukeutuivat otsa- ja ohimolohkon elektroenkefalografia (EEG), lähi-infrapunaspektroskopia, transkraniaalinen Doppler-ultraäänimittaus sekä verestä mitattavat biomerkkiaineet. Biomerkkiaineet kattoivat sekä vakiintuneita aivovauriota heijastavia merkkiaineita (hermostoperäinen enolaasi, proteiini S100β) että useita mielenkiintoisia merkkiaineita, jotka liittyvät kasvaintauteihin ja haimatulehdukseen. Testatuista menetelmistä otsalohkon EEG muuttujat olivat lupaavia, mutta ohimolohkon EEG lisääminen ei parantanut menetelmien herkkyyttä. EEG spektrimuuttujat ennustivat hepaattisen enkefalopatian astetta (I) luotettavasti, kun taas kokeellinen EEG-muuttuja (aalloke-alitaajuuden entropia) ennusti luotettavasti neurologista lopputulosta akuutin maksan vajaatoimintaa sairastavilla potilailla (I). Otsalohkon aivopuoliskojen EEG-rekisteröinnin hetkellinen epäsymmetria ennusti kohtalaisella tarkkuudella neurologisten päätetapahtumien esiintymisen aorttaleikatuilla potilailla (II). Muut testatut menetelmät eivät ennustaneet neurologista lopputulemaa (I, II, IV), paitsi proteiini S100β, joka oli merkittävästi korkeampi 48–72 tuntia leikkauksen jälkeen niillä potilailla, joiden neurologinen toipuminen oli huono (IV). Aorttaleikattujen potilaiden elämänlaatu oli hyvä 5–8 vuotta leikkauksen jälkeen ja verrattavissa kroonisesti sairaan väestön elämänlaatuun (III). Tämän kartoittavan tutkimuksen tarkoituksena oli tunnistaa ja testata ei-kajoavia neuromonitorointimenetelmiä, jotka soveltuvat tehohoitoon. Tulosten perusteella otsalohkon EEG-muuttujat ennustavat hepaattisen enkefalopatian astetta sekä potilaan neurologista toipumista. Muut testatut menetelmät eivät ennustaneet neurologista toipumista luotettavasti. Aorttaleikattujen potilaiden pitkäaikainen (5–8 vuoden) terveyteen liittyvä elämänlaatu on erittäin hyvä, vaikka leikkaukseen liittyy korkea aivovaurion riski

Advanced Signal Processing in Wearable Sensors for Health Monitoring

Smart, wearables devices on a miniature scale are becoming increasingly widely available, typically in the form of smart watches and other connected devices. Consequently, devices to assist in measurements such as electroencephalography (EEG), electrocardiogram (ECG), electromyography (EMG), blood pressure (BP), photoplethysmography (PPG), heart rhythm, respiration rate, apnoea, and motion detection are becoming more available, and play a significant role in healthcare monitoring. The industry is placing great emphasis on making these devices and technologies available on smart devices such as phones and watches. Such measurements are clinically and scientifically useful for real-time monitoring, long-term care, and diagnosis and therapeutic techniques. However, a pertaining issue is that recorded data are usually noisy, contain many artefacts, and are affected by external factors such as movements and physical conditions. In order to obtain accurate and meaningful indicators, the signal has to be processed and conditioned such that the measurements are accurate and free from noise and disturbances. In this context, many researchers have utilized recent technological advances in wearable sensors and signal processing to develop smart and accurate wearable devices for clinical applications. The processing and analysis of physiological signals is a key issue for these smart wearable devices. Consequently, ongoing work in this field of study includes research on filtration, quality checking, signal transformation and decomposition, feature extraction and, most recently, machine learning-based methods

The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In Vivo

BACKGROUND: After ischemia of the CNS, extracellular adenosine 5'-triphosphate (ATP) can reach high concentrations due to cell damage and subsequent increase of membrane permeability. ATP may cause cellular degeneration and death, mediated by P2X and P2Y receptors. METHODOLOGY/PRINCIPAL FINDINGS: The effects of inhibition of P2 receptors by pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) on electrophysiological, functional and morphological alterations in an ischemia model with permanent middle cerebral artery occlusion (MCAO) were investigated up to day 28. Spontaneously hypertensive rats received PPADS or vehicle intracerebroventricularly 15 minutes prior MCAO for up to 7 days. The functional recovery monitored by qEEG was improved by PPADS indicated by an accelerated recovery of ischemia-induced qEEG changes in the delta and alpha frequency bands along with a faster and sustained recovery of motor impairments. Whereas the functional improvements by PPADS were persistent at day 28, the infarct volume measured by magnetic resonance imaging and the amount of TUNEL-positive cells were significantly reduced by PPADS only until day 7. Further, by immunohistochemistry and confocal laser scanning microscopy, we identified both neurons and astrocytes as TUNEL-positive after MCAO. CONCLUSION: The persistent beneficial effect of PPADS on the functional parameters without differences in the late (day 28) infarct size and apoptosis suggests that the early inhibition of P2 receptors might be favourable for the maintenance or early reconstruction of neuronal connectivity in the periinfarct area after ischemic incidents

SLEEPING WHILE AWAKE: A NEUROPHYSIOLOGICAL INVESTIGATION ON SLEEP DURING WAKEFULNESS.

Il sonno e la veglia vengono comunemente considerati come due stati distinti. L\u2019alternanza tra essi, la cui presenza \ue8 stata dimostrata in ogni specie animale studiata fino ad oggi, sembra essere una delle caratteristiche che definisce la nostra vita. Allo stesso tempo, per\uf2, le scoperte portate alla luce negli ultimi decenni hanno offuscato i confini tra questi due stati. I meccanismi del sonno hanno sempre affascinato i neurofisiologi, che infatti, nell\u2019ultimo secolo, li hanno caratterizzati in dettaglio: ora sappiamo che all\u2019attivit\ue0 del sonno sottost\ue0 una specifica attivit\ue0 neuronale chiamata slow oscillation. La slow oscillation, che \ue8 costituita da (ancora una volta) un\u2019alternanza tra periodi di attivit\ue0 e periodi di iperpolarizzazione e silenzio neuronale (OFF-periods), \ue8 la modalit\ue0 base di attivazione del cervello dormiente. Questa alternanza \ue8 dovuta alla tendenza dei neuroni surante lo stato di sonno, di passare ad un periodo silente dopo un\u2019attivazione iniziale, una tendenza a cui viene dato il nome di bistabilit\ue0 neuronale. Molti studi hanno dimostrato come la bistabilit\ue0 neuronale tipica del sonno ed i relativi OFF-periods, possano accadere anche durante la veglia in particolari condizioni patologiche, nelle transizioni del sonno e durante le deprivazioni di sonno. Per questo motivo, se accettassimo che la bistabilit\ue0 neuronale e gli OFF-periods rappresentino una caratteristica fondamentale del sonno, allora dovremmo ammettere che stiamo assistendo ad un cambio di paradigma: da una prospettiva neurofisiologica il sonno pu\uf2 intrudere nella veglia. In questa tesi ho analizzato i nuovi -fluidi- confini tra sonno e veglia e le possibili implicazioni di questi nel problema della persistenza personale attraverso il tempo. Inoltre, ho studiato le implicazioni cliniche dell\u2019intrusione di sonno nella veglia in pazienti con lesioni cerebrali focali di natura ischemica. In particolare, i miei obiettivi sono stati: 1) Dimostrare come la bistabilit\ue0 neuronale possa essere responsabile della perdita di funzione nei pazienti affetti da ischemia cerebrale e come questo potrebbe avere implicazioni nello studio della patofisiologia dell\u2019ischemia cerebrale e nella sua terapia; 2) Stabilire le basi per un modello di sonno locale presente nella vita di tutti i giorni: la sensazione di sonnolenza. Infatti, essa potrebbe riflettere la presenza di porzioni di corteccia in stato di sonno, ma durante lo stato di veglia; 3) Difendere il criterio biologico di identit\ue0, che troverebbe nell\u2019attivit\ue0 cerebrale la continuit\ue0 necessaria al mantenimento della nostra identit\ue0 nel tempo.Sleep and wakefulness are considered two mutually exclusive states. The alternation between those two states seems to be a defining characteristic of our life, a ubiquitous phenomenon demonstrated in every animal species investigated so far. However, during the last decade, advances in neurophysiology have blurred the boundaries between those states. The mechanisms of sleep have always intrigued neurophysiologists and great advances have been made over the last century in understanding them: we now know that the defining characteristic underlying sleep activity is a specific pattern of neuronal activity, namely the slow oscillation. The slow oscillation, which is characterized by the periodic alternation between periods of activity (ON-periods) and periods of hyperpolarization and neuronal silence (OFF-periods) is the default mode of activity of the sleeping cortex. This alternation is due to the tendency of neurons to fall into a silent period after an initial activation; such tendency is known as \u201cbistability\u201d. There is accumulating evidence that sleep-like bistability, and the ensuing OFF-periods, may occur locally in the awake human brain in some pathological conditions, in sleep transition, as well as after sleep deprivation. Therefore, to the extent that bistability and OFF periods represents the basic neuronal features of sleep, a paradigm shift is in place: from a neurophysiological perspective sleep can intrude into wakefulness. In this thesis, I explore the fluid boundaries between sleep and wakefulness and investigate their possible implications on the problem of personal persistence over time. Moreover, I study the clinical implications of the intrusion of sleep into wakefulness in patients with focal brain injury due to stroke. Specifically, I aim to: 1) show how the sleep-like bistability can be responsible for the loss of function in stroke patients. This may have implications for understanding the pathophysiology of stroke and helping to foster recovery; 2) establish the basis for a model of local sleep that might be present in the everyday life, id est the sensation of sleepiness. Indeed, sleepiness could reflect islands of sleep during wakefulness; 3) advocate the biological criterion of identity, in which the continuity necessary for maintaining ourselves over time could be represented by never resting activity in the brain

An in-depth characterisation of neonatal seizures by early continuous video-EEG analysis

Introduction Seizures are harmful to the neonatal brain; this compels many clinicians and researchers to persevere further in optimizing every aspects of managing neonatal seizures. Aims To delineate the seizure profile between non-cooled versus cooled neonates with hypoxic-ischaemic encephalopathy (HIE), in neonates with stroke, the response of seizure burden to phenobarbitone and to quantify the degree of electroclinical dissociation (ECD) of seizures. Methods The multichannel video-EEG was used in this research study as the gold standard to detect seizures, allowing accurate quantification of seizure burden to be ascertained in term neonates. The entire EEG recording for each neonate was independently reviewed by at least 1 experienced neurophysiologist. Data were expressed in medians and interquartile ranges. Linear mixed models results were presented as mean (95% confidence interval); p values <0.05 were deemed as significant. Results Seizure burden in cooled neonates was lower than in non-cooled neonates [60(39-224) vs 203(141-406) minutes; p=0.027]. Seizure burden was reduced in cooled neonates with moderate HIE [49(26-89) vs 162(97-262) minutes; p=0.020] when compared with severe HIE. In neonates with stroke, the background pattern showed suppression over the infarcted side and seizures demonstrated a characteristic pattern. Compared with 10 mg/kg, phenobarbitone doses at 20 mg/kg reduced seizure burden (p=0.004). Seizure burden was reduced within 1 hour of phenobarbitone administration [mean (95% confidence interval): -14(-20 to -8) minutes/hour; p<0.001], but seizures returned to pre-treatment levels within 4 hours (p=0.064). The ECD index in cooled, non-cooled neonates with HIE, stroke and in neonates with other diagnoses were 88%, 94%, 64% and 75% respectively. Conclusions Further research exploring the treatment effects on seizure burden in the neonatal brain is required. A change to our current treatment strategy is warranted as we continue to strive for more effective seizure control, anchored with use of the multichannel EEG as the surveillance tool